Ignite Creation Date:
2024-05-06 @ 2:22 PM
Last Modification Date:
2024-10-26 @ 1:29 PM
Study NCT ID:
NCT04295785
Status:
UNKNOWN
Last Update Posted:
2020-03-05
First Post:
2020-01-09
Brief Title:
Juvenile Autoimmune Necrotizing Myopathies
Sponsor:
Central Hospital Nancy France
Organization:
Central Hospital Nancy France
Study Overview
Official Title:
Clinical Paraclinical Functional Characteristics and Evolution of Juvenile Autoimmune Necrotizing Myopathies in a National Retrospective Cohort
Status:
UNKNOWN
Status Verified Date:
2020-01
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MYONECPED
Brief Summary:
Autoimmune necrotizing myopathies AINM in adult patients are characterized by severity of muscle damage presence of necrosis with little inflammation on muscle biopsy and anti-HMGCR or anti-SRP auto-antibodies Data on AINM in children are currently lacking The purpose of this study is to specify the characteristics at AINM diagnosis treatments and evolution of juvenile AINM with anti-HMGCR or anti-SRP antibodies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None